Knatterud GL, Rosenberg Y, Campeau L, Geller NL, Hunninghake DB, Forman SA, Forrester JS, Gobel FL, Herd JA, Hickey A, Hoogwerf BJ, Terrin ML, White C. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anti- coagulation in the Post Coronary Artery Bypass Graft Trial: Post CABG Investigators. Circulation. 2000;102:157 165. 88. Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications fol- lowing CABG. Eur J Cardiothorac Surg. 1999;15:394 399. 89. Christenson JT. Preoperative lipid control with simvastatin protects coro- nary artery bypass grafts from obstructive graft disease. Am J Cardiol. 2001;88:896 899, A8. 90. Aihara K, Miyauchi K, Kasai T, Kubota N, Kajimoto K, Tamura H, Kojima T,Yokoyama K, Kurata T, Amano A, Daida H. Long-term efficacy of pravastatin therapy in diabetic patients undergoing complete coronary revascularization. J Atheroscler Thromb. 2010;17:350 355. 91. Gan HL, Zhang JQ, Bo P, Wang SX, Lu CS. Statins decrease adverse out- comes in coronary artery bypass for extensive coronary artery disease as well as left main coronary stenosis. Cardiovasc Ther. 2010;28:70 79. doi: 10.1111/j.1755-5922.2009.00098.x. 92. Carrier M, Cossette M, Pellerin M, H bert Y, Bouchard D, Cartier R, Demers P, Jeanmart H, Pag P, Perrault LP. Statin treatment equalizes long-term survival between patients with single and bilateral internal tho- racic artery grafts. Ann Thorac Surg. 2009;88:789 795. doi: 10.1016/j. athoracsur.2009.04.097. 93. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109(suppl 1):III39 III43. doi: 10.1161/01. CIR.0000131517.20177.5a. 94. Lazar HL. Role of statin therapy in the coronary bypass patient. Ann Thorac Surg. 2004;78:730 740. doi: 10.1016/j.athoracsur.2003.12.041. 95. McFarlane SI, Muniyappa R, Francisco R, Sowers JR. Clinical review 145: pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab. 2002;87:1451 1458. doi: 10.1210/jcem.87.4.8412. 96. 